The tweet was deleted by the author.
But we saved everything 🙂.
Veradigm presented research comparing the effectiveness of receiving flu and COVID-19 vaccines together for children in the U.S.
The results were shared at the #ISPOREurope2026 conference and focus on vaccine outcomes among pediatric populations. No additional data or specific findings were disclosed in the company announcement.
View post on X Loading...
Veradigm previously presented research on testing and evaluation gaps before testicular cancer diagnosis in young men at ISPOREU2026. The company has also earned HITRUST i1 certification for 16 solutions, including EHR and ePrescribe, reflecting a focus on healthcare data security and compliance earlier this year. These developments come as Veradigm continues to share new studies on pediatric and young adult healthcare outcomes.